{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:57:55Z","timestamp":1747166275983,"version":"3.40.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jss.2015.05.026","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T06:29:44Z","timestamp":1432189784000},"page":"175-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Esmolol: immunomodulator in pyelonephritis by Pseudomonas aeruginosa"],"prefix":"10.1016","volume":"198","author":[{"given":"George","family":"Dimopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Theodorakopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Armaganidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira-Maria","family":"Tzepi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lignos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-3911","authenticated-orcid":false,"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3775-2850","authenticated-orcid":false,"given":"Thomas","family":"Tsaganos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2015.05.026_bib1","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2353\/ajpath.2007.060872","article-title":"Pathophysiology of sepsis","volume":"170","author":"Remick","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jss.2015.05.026_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/SHK.0b013e318237d6bf","article-title":"Comparison of mortality associated with sepsis in the burn, trauma, and general intensive care unit patient: a systematic review of the literature","volume":"37","author":"Mann","year":"2012","journal-title":"Shock"},{"key":"10.1016\/j.jss.2015.05.026_bib3","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1086\/340616","article-title":"Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization","volume":"34","author":"Blot","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jss.2015.05.026_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jss.2015.05.026_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/14728214.2012.697151","article-title":"Emerging drugs for the treatment of sepsis","volume":"17","author":"Kotsaki","year":"2012","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.jss.2015.05.026_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000658-196901000-00007","article-title":"The treatment of endotoxin shock by beta adrenergic blockade","volume":"169","author":"Berk","year":"1969","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2015.05.026_bib7","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s00134-011-2236-y","article-title":"Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock","volume":"37","author":"Aboab","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jss.2015.05.026_bib8","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1097\/01.CCM.0000182796.11329.3B","article-title":"Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats","volume":"33","author":"Suzuki","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jss.2015.05.026_bib9","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00134-011-2326-x","article-title":"Beta-1 blocker improves survival of septic rats through preservation of gut barrier function","volume":"37","author":"Mori","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jss.2015.05.026_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2334-6-31","article-title":"Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa","volume":"6","author":"Giamarellos-Bourboulis","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jss.2015.05.026_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/jac\/47.5.617","article-title":"In\u00a0vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model","volume":"47","author":"Robaux","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jss.2015.05.026_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1570-0232(02)00273-8","article-title":"Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples","volume":"775","author":"Agarwal","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jss.2015.05.026_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1128\/AAC.48.1.93-99.2004","article-title":"Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa","volume":"48","author":"Giamarellos-Bourboulis","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jss.2015.05.026_bib14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/jac\/dkl084","article-title":"Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae","volume":"57","author":"Giamarellos-Bourboulis","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jss.2015.05.026_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2249.2007.03392.x","article-title":"Early apoptosis of blood monocytes is a determinant of survival in experimental sepsis by multi-drug-resistant Pseudomonas aeruginosa","volume":"149","author":"Antonopoulou","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jss.2015.05.026_bib16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00000539-200109000-00021","article-title":"A comparison of atenolol, labetalol, esmolol, and landiolol for altering human neutrophil functions","volume":"93","author":"Nishina","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jss.2015.05.026_bib17","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis Definitions Conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jss.2015.05.026_bib18","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/cc11930","article-title":"Compartmentalization of lipid peroxidation in sepsis by multidrug-resistant gram-negative bacteria: experimental and clinical evidence","volume":"17","author":"Toufekoula","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.jss.2015.05.026_bib19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/339549","article-title":"Clinical trials of immunomodulatory therapies in severe sepsis and septic shock","volume":"34","author":"Vincent","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jss.2015.05.026_bib20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.resuscitation.2006.07.001","article-title":"beta-Adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis","volume":"72","author":"Schmitz","year":"2007","journal-title":"Resuscitation"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480415006071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480415006071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T08:55:57Z","timestamp":1537606557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480415006071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0022480415006071"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2015.05.026","relation":{},"ISSN":["0022-4804"],"issn-type":[{"type":"print","value":"0022-4804"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esmolol: immunomodulator in pyelonephritis by Pseudomonas aeruginosa","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2015.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}